France· FR:69281980
NORGALAX, gel rectal en récipient unidose
A medicinal product containing docusate de sodium, registered in France by ESSENTIAL PHARMA (M) (MALTE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DOCUSATE DE SODIUM
- Manufacturer
- ESSENTIAL PHARMA (M) (MALTE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009326911666 récipient(s) unidose(s) polyéthylène basse densité (PEBD) avec canule(s) polyéthylène de 10 g
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Docusate de sodium in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesbasic care stool softenerAmazon.com Services LLC
- CanadaANTI BLOATPROFESSIONAL VETERINARY LABORATORIES
- PolandLaxolWrocławskie Zakłady Zielarskie "Herbapol" S.A.
- BelgiumNorgalax 120 mgEssential Pharma (M)
- IrelandWAXSOL 0.5% w/v Ear Drops SolutionCooper Consumer Health B.V.
- NetherlandsNorgalax 0,12 g/10 g, gel voor rectaal gebruikEssential Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Norgalax
- United Kingdom (Northern Ireland) · Dioctyl, Docusate Sodium Adult Typharm
- Ireland · Waxsol
- Luxembourg · Norgalax
- Netherlands · Norgalax
- Poland · Laxol, Ulgix Laxi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/40783fa4-62c2-4172-a875-e30fee4e25de GET /v1/drugs/40783fa4-62c2-4172-a875-e30fee4e25de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69281980",
"date_amm": "1984-03-26",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "DOCUSATE DE SODIUM",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gel",
"voies_administration": "rectale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about docusate de sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.